Back to UBS Group AG UBS Group AG

BBNXBBNX
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in BETA BIONICS INC

UBS Group AG holds 386,623 shares of BBNX (BETA BIONICS INC), worth $6.1M as of 2026-Q2. The position was decreased (-38.0% shares). BBNX represents 0.0% of UBS Group AG's portfolio.

Current Value

$6.1M

Current Shares

386,623

Total Value Change

+$4.5M

Total Shares Change

+262,283

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
386,623
-38.0%
$6.1M0.0%$15.67
0
2026-Q1
Increased
623,253
+147.9%
$6.2M0.0%$11.57
44
2025-Q4
Increased
251,438
+96.6%
$7.7M0.0%$31.97
44
2025-Q3
Increased
127,905
+33.1%
$2.5M0.0%$19.85
34
2025-Q2
Decreased
96,061
-22.7%
$1.4M0.0%$15.07
0
2025-Q1
New
124,340
-
$1.5M0.0%$11.71
35

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used